‘Real’ big data – Quantity and diversity

Host: Bissan Al-Lazikani, The Institute of Cancer Research, UK


Room: Default Location

Recent technological advances have increased our ability to collect data beyond genomics, spanning multiomics, imaging, drug and physical therapy modalities and patient driven data.

What is more, we are now requiring increasingly advanced analytics technologies to deal with these vast and sparse data that are much greater than patient numbers

This session will cover:
– The diversity of data and analytics
– Cancer molecular comics
– Cancer imaging and radiomics
– Novel analytics